Concepedia
Statistics
Publications
17
Citations
852
H-Index
14
Active since
1966
Affiliations
AstraZeneca (Sweden)(Current)
AstraZeneca (United Kingdom)
Karolinska Institutet
Science for Life Laboratory
Karolinska University Hospital
Britt‐Marie Swahn is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and biochemistry.
Top concepts
PharmacologyMedicineBiochemistryDrug DiscoveryNatural SciencesMedicinal ChemistryEngineeringNeuroscienceDrug DevelopmentMolecular Imaging
Publications per year
1966–2014
Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand
Anders Juréus, Britt‐Marie Swahn, Johan Sandell et al. · Journal of Neurochemistry · 2010 · 139 citations
Positron Emission Tomography, Neuroimaging Biomarkers, Neurodegenerative Diseases +14
Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease
Fredrik Jeppsson, Susanna Eketjäll, Juliette Janson et al. · Journal of Biological Chemistry · 2012 · 134 citations · Full text
Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides
Britt‐Marie Swahn, Karin Kolmodin, Sofia Karlström et al. · Journal of Medicinal Chemistry · 2012 · 98 citations · Full text
Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3
Britt‐Marie Swahn, Fernando F. Huerta, Elisabet Kallin et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 68 citations · Full text
Medicinal Chemistry, Biochemistry, Medicine +10
New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain
Ylva Gravenfors, Jenny Viklund, Jan Blid et al. · Journal of Medicinal Chemistry · 2012 · 65 citations · Full text
New Aminoimidazoles, Neurochemical Biomarkers, Pharmaceutical Chemistry +23
1–5 of 17